| Literature DB >> 25152487 |
Carolina Gallego-Iradi1, Justin S Bickford2, Swati Khare1, Alexis Hall1, Jerelyn A Nick1, Donya Salmasinia1, Kolja Wawrowsky3, Serguei Bannykh4, Duong P Huynh5, Diego E Rincon-Limas1, Stefan M Pulst5, Harry S Nick2, Pedro Fernandez-Funez6, Michael F Waters7.
Abstract
<span class="Disease">Spinocerebellar ataxia 13 (SCA13) is an <span class="Disease">autosomal dominant disease resulting from mutations in KCNC3 (Kv3.3), a voltage-gated potassium channel. The KCNC3(R420H) mutation was first identified as causative for SCA13 in a four-generation Filipino kindred with over 20 affected individuals. Electrophysiological analyses in oocytes previously showed that this mutation did not lead to a functional channel and displayed a dominant negative phenotype. In an effort to identify the molecular basis of this allelic form of SCA13, we first determined that human KCNC3(WT) and KCNC3(R420H) display disparate post-translational modifications, and the mutant protein has reduced complex glycan adducts. Immunohistochemical analyses demonstrated that KCNC3(R420H) was not properly trafficking to the plasma membrane and surface biotinylation demonstrated that KCNC3(R420H) exhibited only 24% as much surface expression as KCNC3(WT). KCNC3(R420H) trafficked through the ER but was retained in the Golgi. KCNC3(R420H) expression results in altered Golgi and cellular morphology. Electron microscopy of KCNC3(R420H) localization further supports retention in the Golgi. These results are specific to the KCNC3(R420H) allele and provide new insight into the molecular basis of disease manifestation in SCA13.Entities:
Keywords: Dominant inheritance; Golgi; KCNC3; Protein trafficking; SCA13; Spinocerebellar ataxia; Voltage-gated potassium channel
Mesh:
Substances:
Year: 2014 PMID: 25152487 PMCID: PMC4181561 DOI: 10.1016/j.nbd.2014.08.020
Source DB: PubMed Journal: Neurobiol Dis ISSN: 0969-9961 Impact factor: 5.996